6,874 followers
Phase 1 Study: Selinexor and ibrutinib in B-cell malignancies. https://t.co/9ef0zg9q4K https://t.co/ItAe1HlaaA
Phase 1 Study: Selinexor and ibrutinib in B-cell malignancies. https://t.co/9ef0zg9q4K https://t.co/ItAe1HlaaA
Combination therapy for CLL and NHL. https://t.co/C6wJv6gGzE
RT @CCR_AACR: Combination of #selinexor and #ibrutinib induced responses and was tolerated in #ChronicLymphocyticLeukemia and #NonHodgkinLy…